Anti-TNF Therapy Against Congestive Heart Failure Trial - ATTACH

Description:

The goal of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial was to evaluate the efficacy and safety of infliximab, a chimeric monoclonal antibody to tumor necrosis factor (TNF)-alpha, in patients with moderate to severe heart failure.